CN Stock MarketDetailed Quotes

002365 Qianjiang Yongan Pharmaceutical

Watchlist
  • 12.38
  • +1.13+10.04%
Market Closed Apr 24 15:00 CST
3.65BMarket Cap58.95P/E (TTM)

About Qianjiang Yongan Pharmaceutical Company

The company was founded in 2001. The company's stock was listed on the Shenzhen Stock Exchange on March 5, 2010. The company has strong technical development capabilities, and is an innovative enterprise in Hubei Province and a demonstration enterprise for intellectual property construction in Hubei Province. The company's R&D platform was recognized as a provincial enterprise technology center and Hubei Functional Food Additives Engineering Technology Research Center respectively. It is mainly engaged in three types of business. One is R&D, production and sales of taurine products; the second is the R&D, production and sales of health foods; and the third is R&D, production and sales of special diet foods (creatine). The main products include taurine products, health foods, special dietary foods (creatine), etc. Over the years, the company has been rated as “Advanced Industrial Enterprise in Hubei Province”, “Top Ten Pharmaceutical Industry Enterprises in the Province”, “Hubei Province's Top Ten Enterprises with Harmonious Labor Relations”, “Advanced Scientific and Technological Work Unit”, “Top Ten Honest Enterprises”, etc., and has received various honorary titles such as “Charitable and Caring Enterprise”, “Model Workers' Home”, and “Red Flag Unit”. It has been continuously rated as an A-level enterprise with a tax credit rating, and honors such as “an invisible champion model enterprise in the pillar industry segment in Hubei Province.

Company Profile

Short Name-A永安药业
Symbol-A002365
Company NameQianjiang Yongan Pharmaceutical Co., Ltd.
Listing DateMar 5, 2010
Issue Price31.00
Shares Offered23.50M share(s)
FoundedJun 18, 2001
Listed ExchangeSZ Stock Exchange
Legal Representativeyong chen
General Managerrengui hong
Secretaryshengjie xiong
Accounting FirmLixin Certified Public Accountants (Special General Partnership)
Securities Representativexiuli zhao
Legal CounselShanghai AllBright (Wuhan) Law Firm
Employees612
Phone0728-6204039
Office AddressNo. 2 Guangze Avenue, Qianjiang Economic Development Zone, Hubei Province
Zip Code433132
Registered AddressNo. 2 Guangze Avenue, Qianjiang Economic Development Zone, Hubei Province
Fax0728-6202797
Emailtzz@chinataurine.com
Business License429005000012421
BusinessProduction and sale of APIs; production and sale of food additives; production and sale of feed additives; production and sale of chemical products; production and sale of hazardous chemicals (each specific scope is subject to relevant license documents). Operate the export business of the company's own products and related technology; operate the import business of raw and auxiliary materials, mechanical equipment, instruments, spare parts and related technology required for the company's production and scientific research; carry out the enterprise's feed processing and “three to one supplement” business.

Company Executives

  • Name
  • Position
  • Salary
  • yong chen
  • Chairman, Directors, Audit Committee Members
  • 2.57M
  • rengui hong
  • Directors, General Manager
  • 1.86M
  • zidi chen
  • Directors, Executive Deputy General Manager
  • 1.05M
  • bing zhang
  • Independent Directors
  • 80.00K
  • chunxiang zhao
  • Independent Directors, Chairman of the Audit Committee
  • 80.00K
  • xiaohua guo
  • Independent Directors, Audit Committee Member
  • --
  • shengjie xiong
  • Board Secretary, Chief Financial Officer
  • 877.10K
  • xiuli zhao
  • Securities Affairs Representative
  • --
  • shihao dong
  • Chairman of the Supervisory Board, Auditors
  • 1.17M
  • wei ye
  • Deputy General Manager
  • 456.70K
  • xiquan fang
  • Deputy General Manager
  • 1.82M
  • zhihua wang
  • Deputy General Manager
  • 877.80K
  • baineng luo
  • Director of Audit
  • 300.60K
  • qiong wu
  • Other Senior Executives
  • 279.00K
  • shaobo li
  • Senior Management
  • 657.80K
  • weilin duan
  • Employee Supervisors
  • 409.00K
  • wei dong
  • Other Senior Executives
  • 267.40K
  • yonghong deng
  • Other Senior Executives
  • 267.00K
  • yanjiao ma
  • Employee Supervisors
  • 94.30K

Market Insights

Discussing

2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current Show More